5th Annual MarketsAndMarkets Next-Gen Immuno-Oncology Conference
Cancer Immunotherapy: accelerating preclinical drug candidate selection using the full advanced human immune system mouse models
Presentation during the event by:
Sebastien Tabruyn, PhD Chief Scientific Officer
Sebastien holds a PhD in Molecular Biology from the University of Liege (Belgium). After 15 years of experience as Project leader in renowned international academic research institutes including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia) and the University of Maastricht (Netherlands), he joined TransCure bioServices in 2013 as Head of Molecular Biology and Oncology. Sebastien Tabruyn published 35 peer-reviewed publications in the field of Oncology, Angiogenesis, Inflammation and Immunity.